FNY Managed Accounts’s Celgene Corp CELG Stock Holding History

FNY Managed Accounts’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-170	Closed	-$5.29K	–	422
2016 Q3	$5.29K	Buy	170 +155	+1,033%	+$16.8K	﹤0.01%	334
2016 Q2	$52	Buy	+15	New	+$1.55K	﹤0.01%	286

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FNY Managed Accounts's CELG Position: Q3 2017 in Review

FNY Managed Accounts sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 50 shares — an estimated $6K sold.

FNY Managed Accounts first reported a position in CELG in Q2 2015 and held it in 4 quarters. The position peaked at $400K in Q1 2016. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

FNY Managed Accounts reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
FNY Managed Accounts sold 50 Celgene Corp shares in Q3 2017, an estimated $6K.
FNY Managed Accounts first reported a position in Celgene Corp in Q2 2015 and held it in 4 quarters.
FNY Managed Accounts's Celgene Corp position peaked at $400K in Q1 2016.
1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on FNY Managed Accounts's 13F filing for Q3 2017, filed 9 Nov 2017.